{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:11:02Z","timestamp":1790143862366,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Successful\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      eradication reduces gastric cancer risk, but residual risk persists in patients with established atrophy or intestinal metaplasia. We integrated multi-database science mapping with independent article-level clinical decision-domain classification to quantify how the research agenda evolved from mucosal recovery to residual-risk management and to identify decision-critical evidence gaps.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Web of Science, Scopus, and PubMed were searched through 27 July 2026. Records were deterministically deduplicated and independently screened. Bibliometric networks, thematic structure, temporal bursts, and cited-reference relationships were analyzed. Two reviewers independently classified each publication into one of five mutually exclusive clinical decision domains. Temporal distributions were compared using Pearson's chi-square test, and a research-priority framework was synthesized by triangulating the quantitative findings with representative clinical evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 778 source records, 283 publications from 1993 to 2026 were included. Reviewer agreement was 78.80% (Cohen's kappa\u2009=\u20090.722). Histological regression and mucosal recovery predominated in 1993\u20132007 (34.7%), whereas surveillance and prevention (39.6%) and risk stratification (30.2%) became dominant in 2008\u20132017 and remained the leading domains in 2018\u20132026. Domain distributions differed significantly across periods (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008) and remained significant after exclusion of the incomplete 2026 publication year. The principal translational gaps were the absence of externally validated multimodal risk thresholds and comparative evidence defining surveillance eligibility, intervals, duration, and outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The field has shifted from asking whether gastric mucosal damage can recover to determining who remains at risk and how that risk should be managed. The resulting clinical decision taxonomy and research-priority framework support future validation of multimodal risk thresholds and comparative surveillance strategies; they do not establish universal surveillance or specific intervals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1962890","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:53:58Z","timestamp":1790142838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From histological recovery to residual gastric cancer risk after Helicobacter pylori eradication: a multi-database bibliometric and clinical decision-domain analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Houshu","family":"Tu","sequence":"first","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Chen","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine","place":["Nanchang, China"]},{"name":"Affiliated Hospital of Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Choi","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1046\/j.1365-2036.2002.01311.x","article-title":"Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis","volume":"16","author":"Ito","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/apt.14424","article-title":"Reversibility of atrophic gastritis and intestinal metaplasia after helicobacter pylori eradication-a prospective study for up to 10 years","volume":"47","author":"Hwang","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s10620-021-07146-4","article-title":"The difference of endoscopic and histologic improvements of atrophic gastritis and intestinal metaplasia after helicobacter pylori eradication","volume":"67","author":"Hwang","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/gutjnl-2016-311685","article-title":"Dynamics of helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial","volume":"67","author":"Mera","year":"2018","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00535-010-0347-9","article-title":"The long-term risk of gastric cancer after the successful eradication of helicobacter pylori","volume":"46","author":"Take","year":"2011","journal-title":"J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00535-019-01639-w","article-title":"Risk of gastric cancer in the second decade of follow-up after helicobacter pylori eradication","volume":"55","author":"Take","year":"2020","journal-title":"J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1365-2036.2010.04277.x","article-title":"Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study","volume":"31","author":"Rugge","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): guideline update 2019","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1055\/a-2529-5025","article-title":"Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): guideline update 2025","volume":"57","author":"Dinis-Ribeiro","year":"2025","journal-title":"Endoscopy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG clinical guideline: diagnosis and management of gastric premalignant conditions","volume":"120","author":"Morgan","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"AGA clinical practice update on screening and surveillance in individuals at increased risk for gastric cancer in the United States: expert review","volume":"168","author":"Shah","year":"2025","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gutjnl-2025-335039","article-title":"Precision risk stratification of primary gastric cancer after eradication of helicobacter pylori by a DNA methylation marker: a multicentre prospective study","volume":"74","author":"Yamada","year":"2025","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1111\/hel.12835","article-title":"Research trends on clinical helicobacter pylori eradication: a bibliometric analysis from 1983 to 2020","volume":"26","author":"Ouyang","year":"2021","journal-title":"Helicobacter"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e12986","DOI":"10.1111\/hel.12986","article-title":"States and hotspots in helicobacter pylori research from 2002 to 2021: a bibliometric analysis","volume":"28","author":"Wang","year":"2023","journal-title":"Helicobacter"},{"key":"B18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: vOSviewer, a computer program for bibliometric mapping","volume":"84","author":"Van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"B20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"2008","author":"Blondel","year":"2008","journal-title":"J Stat Mech Theory Exp"},{"key":"B22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J Am Soc Inf Sci Technol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1024940629314","article-title":"Bursty and hierarchical structure in streams","volume":"7","author":"Kleinberg","year":"2003","journal-title":"Data Min Knowl Discov"},{"key":"B24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis: the updated Sydney system","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions","volume":"160","author":"Piazuelo","year":"2021","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10120-015-0544-6","article-title":"Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan","volume":"19","author":"Mori","year":"2016","journal-title":"Gastric Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/gutjnl-2017-314600","article-title":"Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients","volume":"68","author":"Rugge","year":"2019","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/ijc.30145","article-title":"Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection","volume":"139","author":"Iguchi","year":"2016","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/jgh.15187","article-title":"Risk stratification for gastric cancer after helicobacter pylori eradication: a population-based study on matsu islands","volume":"36","author":"Chiang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10120-018-0803-4","article-title":"Novel epigenetic markers for gastric cancer risk stratification in individuals after helicobacter pylori eradication","volume":"21","author":"Maeda","year":"2018","journal-title":"Gastric Cancer"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1962890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:54:00Z","timestamp":1790142840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1962890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":32,"alternative-id":["10.3389\/fmed.2026.1962890"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1962890","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1962890"}}